Literature DB >> 10561502

FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion.

S Yen1, C Easson, P Nacharaju, M Hutton, S H Yen.   

Abstract

Frontal temporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) is caused by splice site and missense mutations in the tau gene, and characterized by the accumulation of filamentous tau in cerebral neurons and glia. The missense mutations reduce the ability of tau to promote microtubule assembly and increase the ability of tau to form filaments. In this report we demonstrate that mutants V337M and R406W are less susceptible than mutant P301L or corresponding wild type tau to degradation by calpain I. The differences were at least in part due to changes in accessibility of a cleavage site located about 100 amino acids off the carboxy-terminus. The results suggest that the pathogenesis of some forms of FTDP-17 may involve tau accumulation due to decreased proteolytic degradation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10561502     DOI: 10.1016/s0014-5793(99)01427-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Cellular models for tau filament assembly.

Authors:  Li-wen Ko; Michael DeTure; Naruhiko Sahara; Rifki Chihab; Shu-Hui Yen
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

2.  Ethanol enhances tau accumulation in neuroblastoma cells that inducibly express tau.

Authors:  Tania F Gendron; Sharon McCartney; Ena Causevic; Li-Wen Ko; Shu-Hui Yen
Journal:  Neurosci Lett       Date:  2008-07-24       Impact factor: 3.046

3.  Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps.

Authors:  Edward Chang; Sohee Kim; Haishan Yin; Haikady N Nagaraja; Jeff Kuret
Journal:  J Neurochem       Date:  2008-09-18       Impact factor: 5.372

4.  Proteasome degradation of brain cytosolic tau in Alzheimer's disease.

Authors:  Samuel S Yen
Journal:  Int J Clin Exp Pathol       Date:  2011-04-28

Review 5.  The role of MSUT-2 in tau neurotoxicity: a target for neuroprotection in tauopathy?

Authors:  Jeanna M Wheeler; Chris R Guthrie; Brian C Kraemer
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

6.  Concentration-dependent effects of proteasomal inhibition on tau processing in a cellular model of tauopathy.

Authors:  Tadanori Hamano; Tania F Gendron; Li-Wen Ko; Shu-Hui Yen
Journal:  Int J Clin Exp Pathol       Date:  2009-06-15

7.  The slow axonal transport of the microtubule-associated protein tau and the transport rates of different isoforms and mutants in cultured neurons.

Authors:  Michelle A Utton; James Connell; Ayodeji A Asuni; Marjon van Slegtenhorst; Michael Hutton; Rohan de Silva; Andrew J Lees; Chris C J Miller; Brian H Anderton
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

8.  Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions.

Authors:  Ming Cheng Liu; Firas Kobeissy; Wenrong Zheng; Zhiqun Zhang; Ronald L Hayes; Kevin K W Wang
Journal:  ASN Neuro       Date:  2011-02-16       Impact factor: 4.146

9.  Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression.

Authors:  Hsu-Hsin Chen; Peter Liu; Paul Auger; Seung-Hye Lee; Oskar Adolfsson; Lorianne Rey-Bellet; Julien Lafrance-Vanasse; Brad A Friedman; Maria Pihlgren; Andreas Muhs; Andrea Pfeifer; James Ernst; Gai Ayalon; Kristin R Wildsmith; Thomas G Beach; Marcel P van der Brug
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

10.  SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans.

Authors:  Chris R Guthrie; Gerard D Schellenberg; Brian C Kraemer
Journal:  Hum Mol Genet       Date:  2009-03-09       Impact factor: 5.121

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.